Vivjoa — Medical Mutual

Recurrent Vulvovaginal Candidiasis

Initial criteria

Patient has experienced three or more episodes of symptomatic vulvovaginal candidiasis within a one-year period; AND
Patient meets one of the following (a, b, or c):
a. Patient has tried oral fluconazole as maintenance therapy AND had inadequate efficacy; OR
b. Patient meets one of the following (i, ii, or iii):
i. Oral fluconazole is not clinically appropriate for the patient due to drug-drug interactions, as determined by the prescriber; OR
ii. Patient has a fluconazole allergy or intolerance, as determined by the prescriber; OR
iii. Patient is being treated for a Candida species that is not susceptible to fluconazole, as determined by the prescriber; OR
c. Patient has already started on Vivjoa therapy (to complete the course of treatment).

90 days